SNBL USA is pleased to announce our recent partnership with Vince Meador, DVM, PhD. Dr. Meador is dual certified as a Diplomate of American College of Veterinary Pathology in anatomic and clinical pathology and brings over 25 years of drug development experience. His career includes positions at leading companies such as Eli Lilly (Director of Toxicology & Pathology), Amgen (Executive Director, Toxicology) and Covance (VP and Global Head, Pathology). Dr. Meador is currently the owner of Pacific Tox Path, LLC and will provide subject matter expertise, serve as Contributing Scientist on reports, review laboratory operations and collaborate closely with our study teams for seamless integration of study results at our Everett, Washington location.
“Dr. Meador brings a unique skill set that very few organizations are fortunate to have and we are thrilled that our collaboration enables him to be on site each week” said Vice President of Preclinical Sciences, Dr. Tina Rogers. “His drug development experience, report integration perspective and professional/personal impact will add significant value to our clients, staff and organization.”